Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 10, Pages e47599
Publisher
Public Library of Science (PLoS)
Online
2012-10-25
DOI
10.1371/journal.pone.0047599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT
- (2012) Katherine J Aitchison et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
- (2011) Samanta Yubero-Lahoz et al. CLINICAL PHARMACOKINETICS
- The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans
- (2011) C M Hysek et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
- (2011) Kim Wolff et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
- (2011) Elisabet Cuyàs et al. PLoS One
- MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
- (2011) Andrew C. Parrott et al. PSYCHOPHARMACOLOGY
- The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users
- (2010) Ana B Fagundo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Overview of Amphetamine-Type Stimulant Mortality Data – UK, 1997–2007
- (2010) Fabrizio Schifano et al. NEUROPSYCHOBIOLOGY
- Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip™
- (2010) Elisabet Cuyàs et al. PHARMACOGENOMICS
- 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study
- (2009) Rocío Martín-Santos et al. ADDICTION BIOLOGY
- Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion
- (2009) X. Perfetti et al. DRUG METABOLISM AND DISPOSITION
- Perspective: Sex Matters: Gonadal Steroids and the Brain
- (2009) Elizabeth A Young et al. NEUROPSYCHOPHARMACOLOGY
- Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): Synthesis, Isolation, and Characterization of Diastereoisomers
- (2008) Nieves Pizarro et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in Humans
- (2008) Brian O'Mathúna et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
- (2008) S. de Sola LLopis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study
- (2008) Susana de Sola et al. PSYCHOPHARMACOLOGY
- Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults
- (2008) Erin A Kolbrich et al. THERAPEUTIC DRUG MONITORING
- Sex differences in drug abuse
- (2007) Jill B. Becker et al. FRONTIERS IN NEUROENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started